Document is current
Any future updates will be listed below
-
Authors
Liu, Shiwei
Cho, Minyoung
Huang, Yen-Ning
Park, Tamina
Chaudhuri, Soumilee
Rosewood, Thea J.
Bice, Paula J.
Chung, Dongjun
Bennett, David A.
Ertekin-Taner, Nilüfer
Saykin, Andrew J.
Nho, Kwangsik https://orcid.org/0000-0002-7624-3872
-
Funding
Funding for this research was provided by:
National Institutes of Health (P30 AG010133, P30 AG072976, R01 AG019771, R01 AG057739, U19 AG024904, R01 LM013463, R01 AG068193, T32 AG071444, U01 AG068057, U01 AG072177, U19 AG074879, R01 LM012535, U19 AG0748790, Alzheimer's Disease Neuroimaging Initiative Health Enhancement Scientific Program (ADNI HESP) subaward from U19 AG024904, CLEAR-AD Scholarship from U19 AG074879)
- License Information
-
More Information
Article History
Received: 16 February 2025
Accepted: 9 June 2025
First Online: 13 July 2025
Declarations
:
: This study used publicly available datasets, no ethics approval and consent to participate was not required.
: This study used publicly available datasets. All data were anonymized, and no information that could reveal the identity of participants was used. Therefore, consent for publication from individual participants was not required.
: A.S. has received support from Avid Radiopharmaceuticals, a subsidiary of Eli Lilly (in kind contribution of PET tracer precursor) and participated in Scientific Advisory Boards (Bayer Oncology, Eisai, Novo Nordisk, and Siemens Medical Solutions USA, Inc) and an Observational Study Monitoring Board (MESA, NIH NHLBI), as well as several other NIA External Advisory Committees. He also serves as Editor-in-Chief of Brain Imaging and Behavior, a Springer-Nature Journal. S. L., T. R., P. B., D. C., D. B., N. T., K. N., S. C., M. C., Y. H., and T. P. have no interest to declare. The funders had no role in the study's design, the collection, analyses, or interpretation of data, the writing of the manuscript, or the decision to publish the results.
